<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>BioByte 140: Predicting Anti-Cancer Mechanisms of Action with DeepTarget, MOG-DFM Optimizes Therapeutic Peptide Design, and a New Means of Suppressing Inflammation in Autoimmune Diseases  - Hex Index</title>
  <link rel="stylesheet" href="../../styles.css">
</head>
<body class="reading-mode">
  <header class="reading-header">
    <a href="../../index.html" class="back-link">&larr; Back to Library</a>
  </header>
  <main class="reading-content">
    
    <article class="article-page">
      <header class="article-header">
        <h1>BioByte 140: Predicting Anti-Cancer Mechanisms of Action with DeepTarget, MOG-DFM Optimizes Therapeutic Peptide Design, and a New Means of Suppressing Inflammation in Autoimmune Diseases </h1>
        <div class="article-meta">
          <span class="author">By Pranay Satya</span>
          <span class="separator">&middot;</span>
          <a href="../../publication/decodingbio/index.html" class="publication">
            
          </a>
          <span class="separator">&middot;</span><time>Nov 13, 2025</time>
          <span class="separator">&middot;</span>
          <span class="read-time">14 min read</span>
        </div>
      </header>

      
      <section class="deep-dives">
        <h2>Deep Dives</h2>
        <p class="deep-dives-intro">Explore related topics with these Wikipedia articles, rewritten for enjoyable reading:</p>
        <ul class="deep-dive-list">
          
      <li class="deep-dive-item">
        <a href="../../wikipedia/pareto-efficiency/index.html">
          <strong>Pareto efficiency</strong>
          <span class="read-time">10 min read</span>
        </a>
        <p class="topic-summary">The article discusses MOG-DFM&#039;s ability to produce &#039;Pareto-tuned candidate sets&#039; and optimize across &#039;predicted Pareto fronts&#039; - understanding Pareto efficiency and Pareto frontiers is essential for grasping how multi-objective optimization works in therapeutic peptide design</p>
      </li>

      <li class="deep-dive-item">
        <a href="../../wikipedia/crispr-gene-editing/index.html">
          <strong>CRISPR gene editing</strong>
          <span class="read-time">14 min read</span>
        </a>
        <p class="topic-summary">DeepTarget&#039;s core methodology relies on comparing drug responses to genome-wide CRISPR-Cas9 knockout experiments to predict mechanisms of action - understanding how CRISPR knockouts work provides crucial context for the computational approach</p>
      </li>

      <li class="deep-dive-item">
        <a href="../../wikipedia/mechanism-of-action/index.html">
          <strong>Mechanism of action</strong>
          <span class="read-time">10 min read</span>
        </a>
        <p class="topic-summary">The article centers on predicting drug mechanisms of action in cancer treatment, discussing how many successful drugs have unknown MOAs - this Wikipedia article provides the pharmacological foundation for understanding why MOA prediction matters</p>
      </li>
        </ul>
      </section>
    

      <div class="article-excerpt">
        <p><em>Welcome to <a href="https://www.decodingbio.com/">Decoding Bio</a>’s BioByte: each week our writing collective highlight notable news—from the latest scientific papers to the latest funding rounds—and everything in between. All in one place.</em></p><div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="https://substackcdn.com/image/fetch/$s_!Di83!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcedf3fd6-73f0-4bba-872f-ff706f2950c8_1750x1747.jpeg" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="https://substackcdn.com/image/fetch/$s_!Di83!,w_424,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcedf3fd6-73f0-4bba-872f-ff706f2950c8_1750x1747.jpeg 424w, https://substackcdn.com/image/fetch/$s_!Di83!,w_848,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcedf3fd6-73f0-4bba-872f-ff706f2950c8_1750x1747.jpeg 848w, https://substackcdn.com/image/fetch/$s_!Di83!,w_1272,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcedf3fd6-73f0-4bba-872f-ff706f2950c8_1750x1747.jpeg 1272w, https://substackcdn.com/image/fetch/$s_!Di83!,w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcedf3fd6-73f0-4bba-872f-ff706f2950c8_1750x1747.jpeg 1456w" sizes="100vw"><img src="https://substackcdn.com/image/fetch/$s_!Di83!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcedf3fd6-73f0-4bba-872f-ff706f2950c8_1750x1747.jpeg" width="1456" height="1454" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/cedf3fd6-73f0-4bba-872f-ff706f2950c8_1750x1747.jpeg&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:1454,&quot;width&quot;:1456,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:1481286,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:&quot;image/jpeg&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:&quot;https://decodingbio.substack.com/i/178767710?img=https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcedf3fd6-73f0-4bba-872f-ff706f2950c8_1750x1747.jpeg&quot;,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="https://substackcdn.com/image/fetch/$s_!Di83!,w_424,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcedf3fd6-73f0-4bba-872f-ff706f2950c8_1750x1747.jpeg 424w, https://substackcdn.com/image/fetch/$s_!Di83!,w_848,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcedf3fd6-73f0-4bba-872f-ff706f2950c8_1750x1747.jpeg 848w, https://substackcdn.com/image/fetch/$s_!Di83!,w_1272,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcedf3fd6-73f0-4bba-872f-ff706f2950c8_1750x1747.jpeg 1272w, https://substackcdn.com/image/fetch/$s_!Di83!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcedf3fd6-73f0-4bba-872f-ff706f2950c8_1750x1747.jpeg 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"></div></div></div></a></figure></div><p>Peter van der Doort, <em>The Alchemist’s Laboratory</em> (1595) [from Heinrich Khunrath, <em>Amphitheatrum sapientiae aeternae</em>]</p><div class="captioned-image-container"><figure><a class="image-link image2" target="_blank" href="https://substackcdn.com/image/fetch/$s_!OtrO!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc60f4468-bfe6-4949-8b08-dda4d03123fa_9208x816.png" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="https://substackcdn.com/image/fetch/$s_!OtrO!,w_424,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc60f4468-bfe6-4949-8b08-dda4d03123fa_9208x816.png 424w, https://substackcdn.com/image/fetch/$s_!OtrO!,w_848,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc60f4468-bfe6-4949-8b08-dda4d03123fa_9208x816.png 848w, https://substackcdn.com/image/fetch/$s_!OtrO!,w_1272,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc60f4468-bfe6-4949-8b08-dda4d03123fa_9208x816.png 1272w, https://substackcdn.com/image/fetch/$s_!OtrO!,w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc60f4468-bfe6-4949-8b08-dda4d03123fa_9208x816.png 1456w" sizes="100vw"><img src="https://substackcdn.com/image/fetch/$s_!OtrO!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc60f4468-bfe6-4949-8b08-dda4d03123fa_9208x816.png" width="1456" height="129" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/c60f4468-bfe6-4949-8b08-dda4d03123fa_9208x816.png&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:129,&quot;width&quot;:1456,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:4076555,&quot;alt&quot;:&quot;&quot;,&quot;title&quot;:&quot;&quot;,&quot;type&quot;:&quot;image/png&quot;,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:false,&quot;internalRedirect&quot;:null,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" title="" srcset="https://substackcdn.com/image/fetch/$s_!OtrO!,w_424,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc60f4468-bfe6-4949-8b08-dda4d03123fa_9208x816.png 424w, https://substackcdn.com/image/fetch/$s_!OtrO!,w_848,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc60f4468-bfe6-4949-8b08-dda4d03123fa_9208x816.png 848w, https://substackcdn.com/image/fetch/$s_!OtrO!,w_1272,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc60f4468-bfe6-4949-8b08-dda4d03123fa_9208x816.png 1272w, https://substackcdn.com/image/fetch/$s_!OtrO!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc60f4468-bfe6-4949-8b08-dda4d03123fa_9208x816.png 1456w" sizes="100vw"></picture><div></div></div></a></figure></div><p><em>A Note To Our Readers: Following this post, we will be taking a short break from posting, but will be back to regular posting the first week of December. We appreciate your support and stay tuned for more coming soon, Decoders!</em> </p><h2>What we read</h2><h4>Blogs</h4><p><strong><a href="https://www.adaptyvbio.com/blog/mog-dfm/">Designer Spotlight: Navigating the multi-property maze for therapeutic peptide design</a></strong> [Adaptyv Bio, <em>Adaptyv Bio</em>, November 2025 (based on <a href="https://www.alphaxiv.org/abs/2505.07086">original paper</a> by Chen et al., <em>arXiv</em>, May 2025)]</p><p>Biomolecular design is a multi-objective puzzle – therapeutic peptides face tradeoffs on properties such as affinity, stability, solubility, and safety. Navigating to the frontiers of feasible designs is a challenging task: properties are interdependent and sequence-phenotype relationships are non-linear and epistatic, forming a complex, high-dimensional landscape to traverse. Many generative models optimize for a single score and re-train for each desired objective, yielding a slow, brittle exploration of the design space. MOG-DFM (Multi-Objective Guided Discrete Flow Matching) offers a single pre-trained DFM generator that, at sampling time, can steer token-level proposals toward any user-specified set of objectives. This unlocks the ability to produce diverse, Pareto-tuned candidate sets without retraining for every tradeoff – a compelling capability for teams exploring competing design constraints.</p><div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="https://substackcdn.com/image/fetch/$s_!VeG0!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa2722eab-5ead-4205-b8f5-44bc66d47e7b_1600x569.png" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="https://substackcdn.com/image/fetch/$s_!VeG0!,w_424,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa2722eab-5ead-4205-b8f5-44bc66d47e7b_1600x569.png 424w, https://substackcdn.com/image/fetch/$s_!VeG0!,w_848,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa2722eab-5ead-4205-b8f5-44bc66d47e7b_1600x569.png 848w, https://substackcdn.com/image/fetch/$s_!VeG0!,w_1272,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa2722eab-5ead-4205-b8f5-44bc66d47e7b_1600x569.png 1272w, https://substackcdn.com/image/fetch/$s_!VeG0!,w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa2722eab-5ead-4205-b8f5-44bc66d47e7b_1600x569.png 1456w" sizes="100vw"><img src="https://substackcdn.com/image/fetch/$s_!VeG0!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa2722eab-5ead-4205-b8f5-44bc66d47e7b_1600x569.png" width="1456" height="518" data-attrs="{&quot;src&quot;:&quot;https://substack-post-media.s3.amazonaws.com/public/images/a2722eab-5ead-4205-b8f5-44bc66d47e7b_1600x569.png&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:518,&quot;width&quot;:1456,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:null,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:null,&quot;href&quot;:null,&quot;belowTheFold&quot;:true,&quot;topImage&quot;:false,&quot;internalRedirect&quot;:null,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="https://substackcdn.com/image/fetch/$s_!VeG0!,w_424,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa2722eab-5ead-4205-b8f5-44bc66d47e7b_1600x569.png 424w, https://substackcdn.com/image/fetch/$s_!VeG0!,w_848,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa2722eab-5ead-4205-b8f5-44bc66d47e7b_1600x569.png 848w, https://substackcdn.com/image/fetch/$s_!VeG0!,w_1272,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa2722eab-5ead-4205-b8f5-44bc66d47e7b_1600x569.png 1272w, https://substackcdn.com/image/fetch/$s_!VeG0!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fa2722eab-5ead-4205-b8f5-44bc66d47e7b_1600x569.png 1456w" sizes="100vw" loading="lazy"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"></div></div></div></a></figure></div><p>The core development is a lightweight, local guidance rule: for each candidate token change, the algorithm computes a hybrid rank (relative candidate ordering on surrogate property predictors) and directional improvement score (expected improvement on the target tradeoff), measuring how a local edit shifts the multi-objective vector. These scores re-weight the DFM token transition rates so the continuous-time Markov chain sampler preferentially proposes beneficial edits. To avoid per-token ‘myopia’ or conflicting edits across multiple properties, the authors introduce an adaptive hypercone: an angular filter that requires proposed moves to lie within a tunable cone around a target objective direction, preserving coordination across tokens while allowing exploration.</p><p>The hypercone facilitates coordinated improvements across multiple properties and surpasses classical multi-objective optimization baselines on predicted Pareto fronts (hemolysis, half-life, solubility, binding, non-fouling). In silico, MOG-DFM shifts predicted trade-offs substantially (e.g. lower predicted hemolysis and higher solubility &amp; half-life, while retaining affinity). Adaptyv provides wet-lab validation: of the 24 designed 10-mer peptides that were </p></source></source>...</source>
      </div>

      <div class="read-full-article">
        <a href="https://decodingbio.substack.com/p/biobyte-140-predicting-anti-cancer" class="read-button" target="_blank" rel="noopener">
          Read full article on  &rarr;
        </a>
        <p class="copyright-note">
          This excerpt is provided for preview purposes.
          Full article content is available on the original publication.
        </p>
      </div>
    </article>
  
  </main>
</body>
</html>